Mubadala Capital

Light Horse Therapeutics is the gene editing applied to small-molecule drug discovery, pioneering approaches to target the root causes of disabling and life-threatening diseases. Its advanced platform identifies cryptic chemically accessible functional domains within targets that are critical in disease biology. Our initial focus addresses high-value, historically challenging oncology targets with the opportunity to apply the technology to other therapeutic areas in the future.

Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function.

GC Therapeutics specializes in synthetic biology to efficiently program patient-derived stem cells into various cell types. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, enabling streamlined manufacturing and improved quality of cell therapies. Their approach allows for the rapid differentiation of pluripotent stem cells, creating unique SuperCells™ customized for specific medical conditions. The foundational technology was developed in Professor George Church's lab at Harvard Medical School, and the team at GC Therapeutics comprises dedicated biologists and tissue engineers focused on translating this innovative method into practical therapies for patients.

Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.

Andalusia Labs is focused on developing essential digital infrastructure tailored for internet markets, particularly in the realm of digital assets. The company offers a comprehensive platform that includes a security solution and risk management infrastructure specifically designed for the blockchain sector. This platform facilitates the management of significant amounts of digital assets, providing innovative companies worldwide with the tools necessary to navigate the complexities of risk associated with digital transactions. Through its offerings, Andalusia Labs aims to enhance the security and efficiency of the digital asset marketplace.

Huboo is an eCommerce fulfillment partner that offers warehousing, packaging, and delivery services tailored for online sellers. The company utilizes a unique hub model, creating service-led micro warehouses that prioritize a human approach in an industry often characterized by automation. Huboo enables businesses, particularly startups and SMEs, to outsource fulfillment complexities while seamlessly integrating with major sales channels and marketplaces. For larger enterprises, its customized solutions cater to the demands of speed and scale, enhancing efficiency and supporting growth. By providing comprehensive stock management, including storage, picking, packing, and direct shipping from wholesalers, Huboo helps internet retailers optimize their inventory management securely and effectively.

Storyblok GmbH operates a cloud-based content management platform that enables users to upload, manage, and publish content through its APIs. Founded in 2015 and headquartered in Linz, Austria, Storyblok distinguishes itself with customizable content blocks and visual editing tools, catering to both developers and content editors. Unlike traditional headless content management systems, which may prioritize flexibility for developers, Storyblok emphasizes usability for editors, allowing them to create and manage content without requiring coding skills. The platform includes features such as a visual composer, various content types, and extensive API endpoints for e-commerce, facilitating a seamless user experience while handling complex tasks like order management and multilingual product catalogs.

FirstVet is a digital veterinary clinic that offers a video consultation platform to connect pet owners with veterinarians via smartphone, tablet, or computer. Founded in 2016 and headquartered in Stockholm, Sweden, the platform allows users to receive advice on their pets' health and well-being, helping them assess when to seek further care. FirstVet's services include video consultations and medicinal prescriptions, providing a cost-effective and time-efficient alternative to traditional veterinary visits. By leveraging technology, FirstVet aims to enhance pet care and simplify access to veterinary services for pet owners.

TIER Mobility GmbH is a shared micro-mobility provider based in Berlin, Germany, specializing in electric vehicles for local commuting. Founded in 2018, the company offers a variety of light electric vehicles, including e-scooters, e-bikes, and e-mopeds, all accessible through a user-friendly application that allows customers to locate and book vehicles easily. TIER aims to transform urban transportation by reducing reliance on cars and promoting climate-neutral solutions that contribute to a sustainable future. Through its proprietary Energy Network, TIER is committed to fostering environmentally friendly mobility options in cities.

Cazoo Limited operates an online platform that revolutionizes the car buying and rental experience in the UK and Europe. Founded in 2018 and based in London, the company allows customers to buy, finance, or rent used cars entirely online. Users can select from a wide range of vehicles and have their chosen car delivered to their doorstep within hours or opt for collection. Cazoo's mission is to simplify the process of purchasing a car, making it more accessible and efficient for consumers.

Owkin is an artificial intelligence company founded in 2016 with offices in New York and Paris, focused on improving patient outcomes through innovative technology. The company utilizes AI to enhance drug discovery and development, particularly in oncology, by identifying new drug candidates, de-risking clinical trials, and creating diagnostic tools. Owkin's offerings include Okwin Lab, which connects data by therapeutic area; Okwin Loop, which features validated models; and a comprehensive software stack for full-service solutions. The company employs federated learning, enabling collaboration among medical and biopharma partners to extract insights from disparate datasets while safeguarding patient privacy. Owkin has developed a catalog of 30 validated models, with an additional 40 in development, and has raised over $255 million in funding, achieving unicorn status in November 2021. Co-founded by Thomas Clozel and Gilles Wainrib, Owkin aims to transform the landscape of healthcare by delivering tailored treatments for individual patients.

Cazoo Limited operates an online platform that revolutionizes the car buying and rental experience in the UK and Europe. Founded in 2018 and based in London, the company allows customers to buy, finance, or rent used cars entirely online. Users can select from a wide range of vehicles and have their chosen car delivered to their doorstep within hours or opt for collection. Cazoo's mission is to simplify the process of purchasing a car, making it more accessible and efficient for consumers.

Cazoo Limited operates an online platform that revolutionizes the car buying and rental experience in the UK and Europe. Founded in 2018 and based in London, the company allows customers to buy, finance, or rent used cars entirely online. Users can select from a wide range of vehicles and have their chosen car delivered to their doorstep within hours or opt for collection. Cazoo's mission is to simplify the process of purchasing a car, making it more accessible and efficient for consumers.

TIER Mobility GmbH is a shared micro-mobility provider based in Berlin, Germany, specializing in electric vehicles for local commuting. Founded in 2018, the company offers a variety of light electric vehicles, including e-scooters, e-bikes, and e-mopeds, all accessible through a user-friendly application that allows customers to locate and book vehicles easily. TIER aims to transform urban transportation by reducing reliance on cars and promoting climate-neutral solutions that contribute to a sustainable future. Through its proprietary Energy Network, TIER is committed to fostering environmentally friendly mobility options in cities.